Monopar Therapeutics

Home » Monopar Therapeutics

IPO

Monopar Therapeutics

Biopharmaceutical

We are a clinical stage biopharmaceutical company focused on developing proprietary therapeutics designed to improve clinical outcomes for cancer patients.

Symbol

MNPR

Price Range
$8.00 - $10.00

Final Shares
4,444,445

Anticipated Date
October 3, 2019

Underwriters
JONESTRADING

This offering is orderable

To view the prospectus for Monopar Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253